aging-GIP1

Biomarker

1 paper studies it2 findings

  • Humans1

Upstream

2

VCAM1

downin silico1

1 study
  1. VCAM1 impairs aging-GIP1 in silico.

    “provide robust evidence for a detrimental effect of blood levels of apolipoprotein(a) and vascular cell adhesion molecule 1 on aging-GIP1”

    In silico

    Mendelian randomization of genetically independent aging phenotypes identifies LPA and VCAM1 as biological targets for human aging

    Nature agingJan 1, 2022

More on VCAM1

LPA

downin silico1

1 study
  1. LPA impairs aging-GIP1 in silico.

    “provide robust evidence for a detrimental effect of blood levels of apolipoprotein(a) and vascular cell adhesion molecule 1 on aging-GIP1”

    In silico

    Mendelian randomization of genetically independent aging phenotypes identifies LPA and VCAM1 as biological targets for human aging

    Nature agingJan 1, 2022

More on LPA

Latest